Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 November 2015 08:09
Breast cancer kills around 11,500 people in the UK each year
A combination of immunotherapy and chemotherapy could provide the key to treating breast cancer patients who have become resistant to existing drugs, new research suggests.
An international team of scientists tested the dual therapy on mice and say their results were "striking".
Experts at the Breast Cancer Care charity say they hope the study will be followed by further clinical trials and pave the way for the development of better treatments.
Researchers say the fact that the mice stayed free of cancer even after being given fresh tumours suggests the combined treatment provided them with ongoing immune protection.
Breast cancer has not previously been known to respond well to immunotherapy but pairing it with targeted chemotherapy produced some startling results, the research team says.
The therapy prevented tumours in the mice from being able to protect themselves from the immune system, enabling them to be attacked by cancer-fighting immune cells.
The type of cancer used by the team is one known as Her2 positive. It affects up to a fifth of all women with breast cancer and in the majority of cases results in patients becoming resistant to the drug Herceptin and other treatments.
But research leader Dr Philipp Muller, of Switzerland's University of Basel, says the technique made the tumours highly vulnerable to antibody-based immunotherapy.
It saw the mice given a chemotherapy drug and a variety of antibodies, including some which stopped the cancers shielding themselves from the animals' immune systems.
Breast cancer should not mean an end to life's luxuries, and holidaymakers can cover themselves with the help of cancer travel insurance policies.
Breast Cancer Care's Jackie Harris describes the research as interesting and a welcome forward step.
The clinical nurse specialist says the results of the early study open up the possibility of breast cancer patients who have become resistant to current drugs being treated in an alternative way in the future.
She adds that while Her2 positive breast cancer is hard to treat, research will provide the key to more effective treatments being developed.
The new study is published in the Science Translational Medicine journal.
23 March 2017
Passengers on certain flights into the UK will no longer be able to carry laptops and tablets like iPads in their hand luggage.
22 March 2017
Mountaineers looking to scale the world's highest peak may need to shell out for a GPS device, according to Nepal's tourism chief.
21 March 2017
The effects of being in skyscrapers, at concerts or even walking on wobbly bridges could help scientists understand the experiences of dementia sufferers, researchers are claiming.
18 March 2017
A young actor has released pictures of a lump on her throat that turned out to be thyroid cancer, with hopes the image will raise awareness and alert others who may be suffering from the disease.
17 March 2017
A "promising treatment" for aggressive blood cancer needs more evidence of its effectiveness before NHS doctors will be able to prescribe, a watchdog is warning.
16 March 2017
Millions of Brits are opting for coach holidays over jet-setting and cruises, new research indicates.
15 March 2017
Thousands of flights to and from America's north east have been cancelled in preparation for a "life-threatening" storm poised to hit the country.
14 March 2017
Seniors who experience weight loss should not put it down to the normal ageing process, experts are warning.
11 March 2017
Gatwick Airport is insisting it is still a "credible and deliverable" expansion option, as the airport experienced its busiest ever February.
08 March 2017
Strikes by French air traffic controllers (ATCs) are leading to delays and cancellations across the UK.
10 March 2017
Waiting times for kidney transplant patients have fallen significantly, health officials have said.
09 March 2017
A Dutch snowboarder has been fatally injured in the second avalanche to hit the French Alps in 24 hours.